Small peptide formulas versus standard polymeric formulas in critically ill patients with acute gastrointestinal injury: a systematic review and meta-analysis

Youquan Wang, Yanhua Li, Hongxiang Li, Yuting Li, Xinyu Li, Dong ZhangScientific 2023 · DOI

This systematic review and meta-analysis, published in Scientific Reports, evaluates the clinical and nutritional impact of choosing small peptide formulas over standard polymeric formulas for enteral nutrition (tube feeding) in critically ill patients suffering from acute gastrointestinal injury (AGI).

TL;DR

While the choice between small peptide and standard polymeric formulas doesn't appear to affect survival rates, small peptide formulas are associated with higher protein intake, better nutritional markers, and significantly shorter stays in both the ICU and the hospital.

What Problem Does This Paper Address?

In the intensive care unit (ICU), the gut is often "the motor" of multi-organ failure. Critically ill patients frequently develop Acute Gastrointestinal Injury (AGI), where the intestinal barrier is compromised, and the ability to digest and absorb nutrients is severely impaired. This leads to "feeding intolerance," where patients cannot meet their nutritional goals, potentially worsening their prognosis.

Clinicians face a dilemma: Should they use standard polymeric formulas (which contain intact proteins and are closer to a normal diet) or small peptide formulas (which contain "pre-digested" proteins that are theoretically easier to absorb)? Current guidelines are based on low-quality evidence, and previous studies have yielded conflicting results. This paper seeks to provide a definitive comparison through a rigorous meta-analysis of existing clinical trials.

Methods

The researchers conducted a systematic review and meta-analysis following PRISMA guidelines. They searched PubMed, Cochrane, and Embase for randomized controlled trials (RCTs) published between January 1980 and June 2022.

Key methodological features included:

  • Inclusion Criteria: Only RCTs involving adult patients (≥16 years) with AGI grades I–IV.
  • Subgroup Analysis: The authors distinguished between "primary AGI" (direct injury to the gut, like pancreatitis) and "secondary AGI" (gut dysfunction resulting from systemic illness, like sepsis).
  • Statistical Rigor: They used a random-effects model to account for significant heterogeneity between studies and performed sensitivity analyses to ensure the robustness of their findings.

Datasets

The study synthesized data from 10 RCTs involving a total of 589 patients. These trials were conducted across diverse geographic regions, including the USA, France, Brazil, Switzerland, the UK, and Canada. The researchers utilized the Cochrane risk assessment tool to evaluate the quality of each study, noting that while most had a low risk of bias, some lacked clear blinding of participants and personnel.

Key Insights and Ideas

  • The Protein-Calorie Trade-off: Interestingly, patients on standard polymeric formulas had a higher daily calorie intake, but those on small peptide formulas had a higher daily protein intake. The authors suggest this is because polymeric formulas often have lower protein density, requiring higher volumes—and thus more calories—to reach protein targets.
  • Absorption Efficiency: Small peptides can be absorbed by the gut without needing trypsin digestion, leading to a higher utilization rate. This likely explains why the small peptide group showed better "albumin growth" and higher prealbumin levels by day 10.
  • The "Primary AGI" Advantage: The reduction in hospital length of stay was particularly pronounced in patients with primary AGI. This suggests that when the gut itself is the site of the main injury, the "pre-digested" nature of small peptides is most beneficial.
  • No "Osmotic Diarrhea" Penalty: A common concern with small peptide formulas is that their higher osmolality might cause diarrhea. However, this meta-analysis found no significant difference in gastrointestinal adverse events (diarrhea, vomiting, or gastric retention) between the two groups.

Key Results

  • Mortality: No significant difference was found in all-cause mortality (Relative Risk = 0.90).
  • Length of Stay: Small peptide formulas were associated with a 2.23-day reduction in ICU stay and a 1.85-day reduction in overall hospital stay.
  • Protein Intake: The small peptide group achieved a significantly higher mean daily protein intake (Mean Difference = 0.09 g/kg).
  • Nutritional Markers: Small peptide formulas led to significantly higher albumin variation within 7 days and higher prealbumin levels on the 10th day of feeding.

Limitations and Future Work

The authors acknowledge several limitations that necessitate caution:

  1. Small Sample Size: With only 10 trials and fewer than 600 total patients, the power of the study is limited.
  2. High Heterogeneity: There was significant variation ($I^2 > 50\%$) in formula compositions, feeding protocols, and ICU types across the included studies.
  3. Mortality Definitions: The primary outcome of "all-cause mortality" combined 28-day, 90-day, and hospital mortality, which are not perfectly interchangeable.

Future Work: The researchers call for large-scale, multi-center RCTs to confirm these results and specifically investigate long-term clinical outcomes beyond the acute phase of ICU care.

Summary updated

Abstract

Small peptide formulas versus standard polymeric formulas for enteral nutrition in critically ill patients with acute gastrointestinal injury (AGI) have been a topic of debate. A systematic review and meta-analysis were conducted to compare their clinical and nutritional outcomes. Relevant studies from January 1980 to June 2022 were searched in PubMed, Cochrane, and Embase databases. Randomized controlled trials involving AGI grade I-IV patients were included, while children, non-AGI patients, and non-critically ill patients were excluded. Results indicated no significant difference in all-cause mortality. Patients receiving small peptide formulas showed higher daily protein intake, greater albumin growth, and higher prealbumin levels. They also had shorter lengths of stay in the intensive care unit and hospital. Conversely, patients receiving standard polymeric formulas had a higher daily calorie intake. In conclusion, the choice of formula may not affect mortality in critically ill patients with AGI. Small peptide formulas were more conducive to increase daily protein intake, decrease intensive care unit and hospital length of stay. Further large-scale randomized controlled trials evaluating the effects of these two nutritional formulas on clinical and nutritional outcomes in critically ill patients with AGI are needed to confirm these results.
BibTeX
@inproceedings{wang2023small,
  author = {Youquan Wang and Yanhua Li and Hongxiang Li and Yuting Li and Xinyu Li and Dong Zhang},
  title = {{Small peptide formulas versus standard polymeric formulas in critically ill patients with acute gastrointestinal injury: a systematic review and meta-analysis}},
  booktitle = {Scientific},
  year = {2023},
  doi = {10.1038/s41598-023-47422-z},
}
Figure